Published in Int J Radiat Oncol Biol Phys on June 01, 2006
Yttrium-90 microsphere radioembolization for the treatment of liver malignancies: a structured meta-analysis. Eur Radiol (2008) 1.69
Transcatheter intraarterial therapies: rationale and overview. Radiology (2011) 1.59
Early post-treatment FDG PET predicts survival after 90Y microsphere radioembolization in liver-dominant metastatic colorectal cancer. Eur J Nucl Med Mol Imaging (2014) 1.43
Multi-centre phase II clinical trial of yttrium-90 resin microspheres alone in unresectable, chemotherapy refractory colorectal liver metastases. Br J Cancer (2010) 1.39
Radioembolization for the treatment of unresectable hepatocellular carcinoma: a clinical review. World J Gastroenterol (2008) 1.30
Gastroduodenal ulceration associated with radioembolization for the treatment of hepatic tumors: an institutional experience and review of the literature. Dig Dis Sci (2010) 1.25
Liver metastases from colorectal cancer: radioembolization with systemic therapy. Nat Rev Clin Oncol (2009) 1.24
Fibrosis, portal hypertension, and hepatic volume changes induced by intra-arterial radiotherapy with 90yttrium microspheres. Dig Dis Sci (2008) 1.12
Safety and efficacy of Y-90 microsphere treatment in patients with primary and metastatic liver cancer: the tumor selectivity of the treatment as a function of tumor to liver flow ratio. J Transl Med (2007) 1.10
Holmium-166 radioembolization for the treatment of patients with liver metastases: design of the phase I HEPAR trial. J Exp Clin Cancer Res (2010) 0.99
Planning transarterial radioembolization of colorectal liver metastases with Yttrium 90 microspheres: evaluation of a sequential diagnostic approach using radiologic and nuclear medicine imaging techniques. Eur Radiol (2008) 0.98
Biocompatibility, inflammatory response, and recannalization characteristics of nonradioactive resin microspheres: histological findings. Cardiovasc Intervent Radiol (2009) 0.98
Clinical effects of transcatheter hepatic arterial embolization with holmium-166 poly(L-lactic acid) microspheres in healthy pigs. Eur J Nucl Med Mol Imaging (2008) 0.98
Liver-directed therapies in metastatic colorectal cancer. J Gastrointest Oncol (2014) 0.97
Use of yttrium-90 microspheres in patients with advanced hepatocellular carcinoma and portal vein thrombosis. J Vasc Interv Radiol (2010) 0.96
CT-guided radiofrequency ablation as a salvage treatment of colorectal cancer hepatic metastases developing after hepatectomy. J Vasc Interv Radiol (2011) 0.96
Targeted radionuclide therapy. Med Phys (2008) 0.95
Radioembolization of hepatic tumors. J Gastrointest Oncol (2014) 0.94
A systematic review on the safety and efficacy of yttrium-90 radioembolization for unresectable, chemorefractory colorectal cancer liver metastases. J Cancer Res Clin Oncol (2013) 0.93
Side effects of yttrium-90 radioembolization. Front Oncol (2014) 0.93
Yttrium-90 radioembolization for colorectal cancer liver metastases: a single institution experience. Int J Surg Oncol (2011) 0.92
Twelve-year experience of radioembolization for colorectal hepatic metastases in 214 patients: survival by era and chemotherapy. Eur J Nucl Med Mol Imaging (2014) 0.91
Effects of Yttrium-90 selective internal radiation therapy on non-conventional liver tumors. World J Gastroenterol (2015) 0.88
Hepatic radioembolization complicated by gastrointestinal ulceration. Semin Intervent Radiol (2011) 0.88
Perfusion CT best predicts outcome after radioembolization of liver metastases: a comparison of radionuclide and CT imaging techniques. Eur Radiol (2014) 0.87
Preoperative Y-90 microsphere selective internal radiation treatment for tumor downsizing and future liver remnant recruitment: a novel approach to improving the safety of major hepatic resections. World J Surg Oncol (2009) 0.87
Hepatic volume changes induced by radioembolization with 90Y resin microspheres. A single-centre study. Eur J Nucl Med Mol Imaging (2012) 0.87
Clinical and laboratory toxicity after intra-arterial radioembolization with (90)y-microspheres for unresectable liver metastases. PLoS One (2013) 0.86
Yttrium-90 radioembolization of hepatic metastases from colorectal cancer. Front Oncol (2014) 0.85
Selective internal radiation therapy for gastrointestinal neuroendocrine tumour liver metastases: a new and effective modality for treatment. Int J Hepatol (2011) 0.84
Radioembolization of yttrium-90 microspheres for hepatic malignancy. Semin Intervent Radiol (2008) 0.83
Transarterial radioembolization for hepatocellular carcinoma: An update and perspectives. World J Gastroenterol (2015) 0.82
Predictors of response to radio-embolization (TheraSphere®) treatment of neuroendocrine liver metastasis. HPB (Oxford) (2011) 0.82
Selective Interarterial Radiation Therapy (SIRT) in Colorectal Liver Metastases: How Do We Monitor Response? HPB Surg (2013) 0.82
Update and review of the multidisciplinary management of stage IV colorectal cancer with liver metastases. World J Surg Oncol (2009) 0.81
The role of 18F-FDG-PET and PET/CT in patients with colorectal liver metastases undergoing selective internal radiation therapy with yttrium-90: a first evidence-based review. ScientificWorldJournal (2014) 0.80
Radioembolization for primary and metastatic liver cancer. Semin Radiat Oncol (2011) 0.80
Development of a research agenda for the management of metastatic colorectal cancer: proceedings from a multidisciplinary research consensus panel. J Vasc Interv Radiol (2012) 0.80
Initial study of radiological and clinical efficacy radioembolization using 188Re-human serum albumin (HSA) microspheres in patients with progressive, unresectable primary or secondary liver cancers. Med Sci Monit (2014) 0.79
Complete eradication of hepatic metastasis from colorectal cancer by Yttrium-90 SIRT. World J Gastroenterol (2007) 0.79
Current strategies in interventional oncology of colorectal liver metastases. Br J Radiol (2016) 0.79
Intra-arterial therapies for metastatic colorectal cancer. Semin Intervent Radiol (2013) 0.78
Radioembolization for hepatocellular carcinoma using TheraSphere®. Saudi J Gastroenterol (2011) 0.78
Evidence-based medical oncology and interventional radiology paradigms for liver-dominant colorectal cancer metastases. World J Gastroenterol (2016) 0.78
Robust evidence for long-term survival with (90)Y radioembolization in chemorefractory liver-predominant metastatic colorectal cancer. Eur Radiol (2016) 0.78
Radioembolization with Yttrium-90 microspheres in hepatocellular carcinoma: Role and perspectives. World J Hepatol (2015) 0.77
Added value of FDG-PET imaging in the diagnostic workup for yttrium-90 radioembolisation in patients with colorectal cancer liver metastases. Eur Radiol (2012) 0.77
Hepatic imaging response to radioembolization with yttrium-90-labeled resin microspheres for tumor progression during systemic chemotherapy in patients with colorectal liver metastases. J Gastrointest Oncol (2015) 0.77
MRI-based biodistribution assessment of holmium-166 poly(L-lactic acid) microspheres after radioembolisation. Eur Radiol (2012) 0.77
Nomogram including pretherapeutic parameters for prediction of survival after SIRT of hepatic metastases from colorectal cancer. Eur Radiol (2015) 0.77
Non-operative therapies for colorectal liver metastases. J Gastrointest Oncol (2015) 0.76
Direct in vivo injection of 131I-GMS and its distribution and excretion in rabbit. World J Gastroenterol (2010) 0.76
Preparation of porous yttrium oxide microparticles by gelation of ammonium alginate in aqueous solution containing yttrium ions. J Mater Sci Mater Med (2010) 0.75
Gastric injury from (90)Y to left hepatic lobe tumors adjacent to the stomach: fact or fiction? Eur J Nucl Med Mol Imaging (2015) 0.75
Transarterial therapy: an evolving treatment modality of hepatocellular carcinoma. Saudi J Gastroenterol (2014) 0.75
Outcomes and Predictors of Toxicity after Selective Internal Radiation Therapy Using Yttrium-90 Resin Microspheres for Unresectable Hepatocellular Carcinoma. Front Oncol (2015) 0.75
Safety of redo hepatectomy for colorectal liver metastases after selective interarterial radiation therapy: a case report. Case Rep Surg (2014) 0.75
Pretreatment tumor volume as a prognostic factor in metastatic colorectal cancer treated with selective internal radiation to the liver using yttrium-90 resin microspheres. J Gastrointest Oncol (2016) 0.75
Factors associated with increased incidence of severe toxicities following yttrium-90 resin microspheres in the treatment of hepatic malignancies. World J Gastroenterol (2016) 0.75
Transarterial radioembolization for hepatocellular carcinoma: a review. J Hepatocell Carcinoma (2016) 0.75
Yttrium-90 radioembolization for colorectal cancer liver metastases: a prospective cohort study on circulating angiogenic factors and treatment response. EJNMMI Res (2016) 0.75
Transarterial radioembolization using yttrium-90 microspheres in the treatment of hepatocellular carcinoma: a review on clinical utility and developments. J Hepatocell Carcinoma (2014) 0.75
Radioembolization with (90)Y glass microspheres for the treatment of unresectable metastatic liver disease from chemotherapy-refractory gastrointestinal cancers: final report of a prospective pilot study. J Gastrointest Oncol (2016) 0.75
[Intra-arterial treatment of liver metastases from colorectal carcinoma]. J Radiol (2011) 0.75
Preparation and complex characterization of silica holmium sol-gel monoliths. J Mater Sci Mater Med (2010) 0.75
A Comparison of Yttrium-90 Microsphere Radioembolization to Hepatic Arterial Infusional Chemotherapy for Patients with Chemo-refractory Hepatic Colorectal Metastases. Curr Treat Options Oncol (2017) 0.75
Metastatic Liver Disease: Indications for Locoregional Therapy and Supporting Data. Semin Intervent Radiol (2017) 0.75
Recommendations for radioembolization of hepatic malignancies using yttrium-90 microsphere brachytherapy: a consensus panel report from the radioembolization brachytherapy oncology consortium. Int J Radiat Oncol Biol Phys (2007) 3.65
Randomized controlled trial of interval-compressed chemotherapy for the treatment of localized Ewing sarcoma: a report from the Children's Oncology Group. J Clin Oncol (2012) 2.96
Dose-intensified compared with standard chemotherapy for nonmetastatic Ewing sarcoma family of tumors: a Children's Oncology Group Study. J Clin Oncol (2009) 2.44
Use of research biopsies in clinical trials: are risks and benefits adequately discussed? J Clin Oncol (2012) 2.43
The NANETS consensus guideline for the diagnosis and management of neuroendocrine tumors: well-differentiated neuroendocrine tumors of the Jejunum, Ileum, Appendix, and Cecum. Pancreas (2010) 2.13
Pathologic response and microdosimetry of (90)Y microspheres in man: review of four explanted whole livers. Int J Radiat Oncol Biol Phys (2004) 2.11
Hepatic artery embolization and chemoembolization for treatment of patients with metastatic carcinoid tumors: the M.D. Anderson experience. Cancer J (2003) 2.02
Research reporting standards for radioembolization of hepatic malignancies. J Vasc Interv Radiol (2011) 1.89
Splenic arterial interventions: anatomy, indications, technical considerations, and potential complications. Radiographics (2005) 1.85
Radioembolization for unresectable neuroendocrine hepatic metastases using resin 90Y-microspheres: early results in 148 patients. Am J Clin Oncol (2008) 1.84
Radioembolization with 90Y microspheres: angiographic and technical considerations. Cardiovasc Intervent Radiol (2007) 1.73
Hepatic arterial embolization and chemoembolization for the treatment of patients with metastatic neuroendocrine tumors: variables affecting response rates and survival. Cancer (2005) 1.67
Treatment parameters and outcome in 680 treatments of internal radiation with resin 90Y-microspheres for unresectable hepatic tumors. Int J Radiat Oncol Biol Phys (2009) 1.51
Transhepatic ipsilateral right portal vein embolization extended to segment IV: improving hypertrophy and resection outcomes with spherical particles and coils. J Vasc Interv Radiol (2005) 1.43
Biliary sequelae following radioembolization with Yttrium-90 microspheres. J Vasc Interv Radiol (2008) 1.33
Technical aspects of radioembolization with 90Y microspheres. Tech Vasc Interv Radiol (2007) 1.31
Update on the management of neuroendocrine hepatic metastases. J Vasc Interv Radiol (2006) 1.30
Intensification of therapy for children with lower-risk acute lymphoblastic leukemia: long-term follow-up of patients treated on Children's Cancer Group Trial 1881. J Clin Oncol (2003) 1.27
Multimodality imaging following 90Y radioembolization: a comprehensive review and pictorial essay. Radiographics (2008) 1.25
Transcatheter therapy for hepatic malignancy: standardization of terminology and reporting criteria. J Vasc Interv Radiol (2007) 1.16
Transcatheter therapy for hepatic malignancy: standardization of terminology and reporting criteria. J Vasc Interv Radiol (2009) 1.16
[90Y]yttrium microspheres radioembolotherapy in desmoplastic small round cell tumor hepatic metastases. J Clin Oncol (2011) 1.15
Hepatic yttrium-90 radioembolization of chemotherapy-refractory colorectal cancer liver metastases. J Vasc Interv Radiol (2008) 1.14
Impact of C-arm CT on hepatic arterial interventions for hepatic malignancies. J Vasc Interv Radiol (2007) 1.13
Ovarian carcinoma in an adolescent with transgenerational exposure to diethylstilbestrol. J Pediatr Hematol Oncol (2003) 1.11
Small (</=2-cm) subpleural pulmonary lesions: short- versus long-needle-path CT-guided Biopsy--comparison of diagnostic yields and complications. Radiology (2005) 1.11
Radioembolization for the treatment of liver tumors general principles. Am J Clin Oncol (2012) 1.07
Imaging-guided percutaneous biopsy of mediastinal lesions: different approaches and anatomic considerations. Radiographics (2005) 1.06
Radioembolization for hepatocellular carcinoma: a review of the evidence and treatment recommendations. Am J Clin Oncol (2011) 1.06
Radioembolization in patients with hepatic metastases from breast cancer. J Vasc Interv Radiol (2008) 1.03
Interobserver reliability of computed tomography-derived primary tumor volume measurement in patients with supraglottic carcinoma. Cancer (2005) 1.02
An evaluation of the variability of tumor-shape definition derived by experienced observers from CT images of supraglottic carcinomas (ACRIN protocol 6658). Int J Radiat Oncol Biol Phys (2007) 0.99
CT-guided radiofrequency ablation in patients with hepatic metastases from breast cancer. Cardiovasc Intervent Radiol (2008) 0.98
Percutaneous image-guided splenic biopsy in the oncology patient: an audit of 156 consecutive cases. J Vasc Interv Radiol (2008) 0.96
Integrating radioembolization ((90)Y microspheres) into current treatment options for liver tumors: introduction to the international working group report. Am J Clin Oncol (2012) 0.96
Hepatic artery chemoembolization for 110 gastrointestinal stromal tumors: response, survival, and prognostic factors. Cancer (2006) 0.95
Various approaches for CT-guided percutaneous biopsy of deep pelvic lesions: anatomic and technical considerations. Radiographics (2004) 0.93
A first report of radioembolization for hepatic metastases from ocular melanoma. Cancer Invest (2009) 0.92
Treatment of large and advanced hepatocellular carcinoma. Ann Surg Oncol (2008) 0.91
Fistulas of the lower urinary tract: percutaneous approaches for the management of a difficult clinical entity. Radiographics (2004) 0.90
Comparative evaluation of local control strategies in localized Ewing sarcoma of bone: a report from the Children's Oncology Group. Cancer (2014) 0.90
Hepatic arterial embolization and chemoembolization for imatinib-resistant gastrointestinal stromal tumors. Am J Clin Oncol (2009) 0.89
Percutaneous biopsy of head and neck lesions with CT guidance: various approaches and relevant anatomic and technical considerations. Radiographics (2007) 0.89
Use of inferior vena caval filters and survival in patients with malignancy. Cancer (2004) 0.88
Physical aspects of yttrium-90 microsphere therapy for nonresectable hepatic tumors. Med Phys (2003) 0.87
Hepatic arterial embolization and chemoembolization in the management of patients with large-volume liver metastases. Cardiovasc Intervent Radiol (2007) 0.87
Development of a large animal model of cirrhosis and portal hypertension using hepatic transarterial embolization: a study in swine. J Vasc Interv Radiol (2011) 0.85
Temporary balloon occlusion of the common hepatic artery for administration of yttrium-90 resin microspheres in a patient with patent hepatoenteric collaterals. J Vasc Interv Radiol (2012) 0.85
Acute endovascular stent-graft occlusion after treatment of an arterioureteral fistula. J Vasc Interv Radiol (2005) 0.85
Respiratory gating with EPID-based verification: the MDACC experience. Phys Med Biol (2009) 0.84
Outpatient management of postbiopsy pneumothorax with small-caliber chest tubes: factors affecting the need for prolonged drainage and additional interventions. Cardiovasc Intervent Radiol (2007) 0.83
Hepatic artery chemoembolization in patients with ocular melanoma metastatic to the liver: response, survival, and prognostic factors. Am J Clin Oncol (2010) 0.83
Quality improvement guidelines for percutaneous management of acute limb ischemia. J Vasc Interv Radiol (2005) 0.82
Integrating radioembolization into the treatment paradigm for metastatic neuroendocrine tumors in the liver. Am J Clin Oncol (2012) 0.82
Yttrium-90-labeled microsphere radioembolotherapy of liver-dominant metastases from thoracic malignancies. J Vasc Interv Radiol (2008) 0.81
Integrating radioembolization with chemotherapy in the treatment paradigm for unresectable colorectal liver metastases. Am J Clin Oncol (2012) 0.81
Combined antegrade and retrograde embolization of a transected vertebral artery. J Trauma (2003) 0.80
Radioembolization in the treatment of neuroendocrine tumor metastases to the liver. Int J Hepatol (2011) 0.80
Accuracy and sensitivity of computed tomography-guided percutaneous needle biopsy of pulmonary hilar lymph nodes. Cancer (2010) 0.80
Percutaneous transhepatic portal vein embolization: rationale, technique, and outcomes. Semin Intervent Radiol (2008) 0.80
Development of a research agenda for the management of metastatic colorectal cancer: proceedings from a multidisciplinary research consensus panel. J Vasc Interv Radiol (2012) 0.80
CT-guided percutaneous lung biopsies in patients with haematologic malignancies and undiagnosed pulmonary lesions. Hematol Oncol (2010) 0.79
Response, survival, and prognostic factors after hepatic arterial chemoembolization in patients with liver metastases from cutaneous melanoma. Cancer Invest (2011) 0.79
Percutaneous ultrasound-guided biopsy in the definitive diagnosis of osteosarcoma. J Vasc Interv Radiol (2004) 0.78
Minimally invasive techniques in management of hepatic neuroendocrine metastatic disease. Am J Clin Oncol (2009) 0.78
An expanded phase I/II trial of cyclophosphamide, etoposide, and carboplatin plus total body irradiation with autologous marrow or stem cell support for patients with hematologic malignancies. Biol Blood Marrow Transplant (2003) 0.77
Can imaging patterns of neuroendocrine hepatic metastases predict response yttruim-90 radioembolotherapy? World J Radiol (2013) 0.77
Development of a research agenda for interventional oncology: proceedings from an interdisciplinary consensus panel. J Vasc Interv Radiol (2004) 0.77
Gastroduodenal artery recanalization after transcatheter fibered coil embolization for prevention of hepaticoenteric flow: incidence and predisposing technical factors in 142 patients. Acta Radiol (2013) 0.76
Metastatic breast cancer in a 54-year-old woman: integrative treatment with yttrium-90 radioembolization. Integr Cancer Ther (2004) 0.76
Comprehensive Genomic Profiling of Clinically Advanced Medullary Thyroid Carcinoma. Oncology (2016) 0.75
Temporary balloon occlusion of the common hepatic artery for yttrium-90 glass microspheres administration in a patient with hepatocellular cancer and renal insufficiency. Case Rep Radiol (2013) 0.75
What's New in Transarterial Therapies for Hepatocellular Carcinoma? Gastrointest Cancer Res (2012) 0.75
Establishment of the radiation effect of yttrium-90 microspheres: role of C-arm CT. J Vasc Interv Radiol (2009) 0.75
The ACR-RSNA Fellowship in Clinical Trials of Medical Imaging: reflections from the 2002 recipients. Acad Radiol (2003) 0.75
Natural History of T1N0M0 Hepatocellular Carcinoma: Large-Scale Study in the United States. Oncology (2017) 0.75
Axillary artery traumatic pseudoaneurysm managed with a Wallgraft Endoprothesis. J Vasc Interv Radiol (2003) 0.75
Daily targeting of liver tumors: screening patients with a mock treatment and using a combination of internal and external fiducials for image-guided respiratory-gated radiotherapy. Med Phys (2007) 0.75
CT-guided needle biopsy of deep pelvic lesions by extraperitoneal approach through iliopsoas muscle. Cardiovasc Intervent Radiol (2004) 0.75